Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neurologix Q1 net loss narrows
Neurologix is a clinical-stage biotechnology company engaged in discovery, development and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. The
Neurologix is a clinical-stage biotechnology company engaged in discovery, development and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. The
TB-403 is a humanized monoclonal antibody directed towards placental growth factor (PIGF), expected to act by blocking the formation of the new blood vessels that are required for
Fampyra 10mg MR tablet is indicated for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of
Teva intends to extend an offer to purchase all remaining outstanding shares of Taiyo. Taiyo has over 550 generic drugs in a variety of therapeutic areas and dosage
GBR 500 is an antagonist of the VLA-2 (alpha2-beta1) integrin, a receptor that plays a role in lymphocyte adhesion at inflammation sites and in the downstream release of
The FDA has asked the consumers not to buy products labeled as ExtenZe with lot numbers 1110075 and F050899. The agency said the counterfeit product’s packaging is similar
Cyclobenzaprine HCl ER Capsules, 15mg and 30mg are generic version of Amrix capsules. Amrix is a prescription medicine to be used along with rest and physical therapy to
Risperidone Orally Disintegrating Tablets are an atypical antipsychotic that work by affecting certain substances in the brain. Risperidone Orally Disintegrating Tablets 0.5mg, 1mg, 2mg, 3mg and 4mg are
As per the terms of the agreement, Nuvo has issued approximately 99.8 million common shares and paid approximately $0.1m to the shareholders of ZARS, representing approximately 19.2% of
Exparel is Pacira’s proprietary drug candidate consisting of bupivacaine encapsulated in DepoFoam, both of which are currently used separately in FDA-approved products. The study results showed less pain